3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
2
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Solid Tumor Spine Metastases
1
Sarcoma
1
Rectal Neoplasms
1
Oligodendroglioma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Lymphoma, Follicular
1
Locally Advanced Colon Cancer
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Astrocytoma
1
Anxiety Disorders
1
Amenorrhea
1
Interventions
Gemcitabine
15
Mitomycin
10
Docetaxel
7
BCG Vaccine
7
Cystoscopy
4
tislelizumab
3
durvalumab
3
Radiotherapy
3
Epirubicin
3
disitamab vedotin
2
avelumab
2
Hyaluronic Acid
2
tremelimumab
1
toripalimab
1
pemigatinib
1
pembrolizumab
1
monalizumab
1
lornoxicam
1
erdafitinib
1
enzalutamide
1
chondroitin sulfate, sodium hyaluronate drug combination
1
bicalutamide
1
Watchful Waiting
1
VPM1002 recombinant BCG vaccine
1
Urine Specimen Collection
1
Ty21a typhoid vaccine
1
Transurethral Resection of Bladder
1
Therapeutics
1
Surveys and Questionnaires
1
Sugars
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Non-Muscle Invasive Bladder Neoplasms
×
Postoperative Period
×
Clear all
NCT02075060
2017-04-06
IPOI vs IPOP
Poitiers University Hospital
Phase 2
Unknown
54 enrolled